Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Global Hospital Supplies Market Briefing 2018 Featuring Johnson & Johnson, GE Healthcare, Cardinal Health, Medline Industries & B. Braun Melsungen - ResearchAndMarkets.com

The "Hospital Supplies Market Global Briefing 2018" report has been added to ResearchAndMarkets.com's offering.

JNJ : 129.91 (-0.73%)
ERLEADA (Apalutamide), the First FDA-Approved Treatment for Non-Metastatic, Castration-Resistant Prostate Cancer, Available for Order at Biologics, Inc.

Biologics, Inc., a McKesson Specialty Health oncology and complex care pharmacy services company, has been selected by the Janssen Pharmaceutical Companies of Johnson & Johnson(1)...

JNJ : 129.91 (-0.73%)
J&J Does Best in Attracting Young, High-Achieving Immuno-Oncology Researchers, According to Data Analytics Firm hiQ Labs

Johnson & Johnson is the premier destination for elite, high-achieving young Immuno-Oncology (I-O) professionals, according to a new study issued by hiQ Labs, a research firm that analyzes publicly available...

JNJ : 129.91 (-0.73%)
Global Contact Lenses and Solutions Strategic Business Report 2018 Featuring Alcon, Bausch & Lomb, CooperVision, Ginko, Johnson & Johnson and St. Shine Optical

The "Contact Lenses and Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

JNJ : 129.91 (-0.73%)
Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 38th Annual Healthcare Conference on Tuesday, Mar. 13, at The Boston Marriott Copley Place, Boston. Ashley McEvoy, Company Group Chairman, Consumer...

JNJ : 129.91 (-0.73%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 - JNJ

The following statement is being issued by Levi & Korsinsky, LLP:

JNJ : 129.91 (-0.73%)
What's in the Cards for Geron (GERN) This Earnings Season?

With no approved product in Geron's (GERN) portfolio, investor focus is likely to remain on its sole pipeline candidate, imetelstat, in the Q4 release.

EXAS : 46.64 (-2.85%)
JNJ : 129.91 (-0.73%)
EXEL : 28.99 (+0.55%)
GERN : 2.25 (+0.45%)
Iron Deficiency Anemia - Pipeline Insight, 2018 Featuring Johnson & Johnson, Novartis, Pieris Pharmaceuticals, Rockwell Medical & Shield Therapeutics - ResearchAndMarkets.com

The "Iron Deficiency Anemia - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

JNJ : 129.91 (-0.73%)
NVS : 84.89 (-0.56%)
PIRS : 8.12 (-5.14%)
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics

Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including...

JNJ : 129.91 (-0.73%)
Global Over-the-Counter (OTC) Drug Markets 2017-2023: Johnson & Johnson Maintains a Top Market Position Despite Growing Consolidation and Competition - ResearchAndMarkets.com

The "Global Over-the-Counter (OTC) Drug Markets" report has been added to ResearchAndMarkets.com's offering.

JNJ : 129.91 (-0.73%)
World's Largest Recovery App, Sober Grid, Can Now Predict Relapses with Artificial Intelligence

Sober Grid, Inc., a National Science Foundation and National Institute of Health backed company, in partnership with UPenn Perelman School of Medicine, has successfully predicted if someone is going to...

JNJ : 129.91 (-0.73%)
Stocks stretch winning streak to 6 days despite turbulence

NEW YORK (AP) — Stocks closed out their strongest week in five years Friday and have now recovered more than half of the losses they suffered in a plunge at the beginning of the month.

VFC : 74.50 (+1.26%)
CPB : 42.90 (-6.90%)
WFC : 59.73 (-0.37%)
JNJ : 129.91 (-0.73%)
HD : 183.06 (-1.95%)
PFE : 35.76 (-0.69%)
Markets Right Now: Stocks rise for the 6th straight day

NEW YORK (AP) — The latest on developments in financial markets (all times local):

JNJ : 129.91 (-0.73%)
The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson

The Klein Law Firm announces the commencement of an investigation of Johnson & Johnson (NYSE: JNJ) concerning possible violations of federal securities laws.

JNJ : 129.91 (-0.73%)
Watch for Johnson&Johnson to Potentially Pullback After Gaining 1.76% Yesterday

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $130.84 to a high of $133.85. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of...

JNJ : 129.91 (-0.73%)
After Yesterday's Rally of 1.76% Shares Could Potentially Pullback

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $130.84 to a high of $133.85. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of...

JNJ : 129.91 (-0.73%)
Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting

Reinforcing leadership in scientifically-driven skincare, Johnson & Johnson Consumer Inc. will present eight Scientific Posters at this year's American Academy of Dermatology (AAD) Annual Meeting in San...

JNJ : 129.91 (-0.73%)
Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34%

The Dow rebounded strongly over the first five trading days after entering correction territory last week.

CSCO : 43.31 (-1.70%)
V : 120.43 (-1.29%)
JNJ : 129.91 (-0.73%)
CAT : 155.23 (-0.21%)
XOM : 74.89 (-1.14%)
GS : 263.40 (-0.56%)
AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan

AbbVie (ABBV) announces a 35% hike in its quarterly dividend along with the authorization of a new $10 billion share buyback program by the board.

JNJ : 129.91 (-0.73%)
ABBV : 117.91 (-0.06%)
RHHBY : 29.6200 (-0.50%)
AMGN : 182.43 (-0.30%)
J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised)

J&J (JNJ) Gets FDA approval for Erleada (apalutamide) for the treatment of non-metastatic castration-resistant prostate cancer.

MYL : 41.21 (-0.31%)
RDY : 33.56 (-1.44%)
JNJ : 129.91 (-0.73%)
TEVA : 20.09 (+0.55%)

Van Meerten Stock Picks

Nvidia - My Favorite S\&P 500 Large Cap Stock
$NVDA Summary96% technical by signals.
NVDA -7.57
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 unch) this morning are down -0.05% and European stocks are down -0.57% after European manufacturing activity slowed more than expected this month. Losses were contained as the 10-year... Read More

Chart of the Day

Match Group Inc CS (MTCH)

Match Group (MTCH) is the Barchart Chart of the Day.  The popular on-line dating company has a Trend Spotter buy signal, a Weighted Alpha of 190.79+ and gained 152.84% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures showed fractional gains on Wednesday. The weekly EIA report will be delayed until Thursday morning, as ethanol production fell to 1.016 million bpd in last week’s report. Ahead of the USDA Ag Outlook Forum, a Reuters survey of anal...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.